Financial statements Bio Innovative Technology
Balance sheet data of BIO INNOVATIVE TECHNOLOGY
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 167 581,29 | 163 231,76 | 126 747,70 | 138 499,91 | 115 712,05 | 104 656,04 |
A. Fixed assets | 1 775,20 | 760,80 | 0,00 | 7 803,00 | 5 967,00 | 4 131,00 |
B. Current assets | 165 806,09 | 162 470,96 | 126 747,70 | 130 696,91 | 109 745,05 | 100 525,04 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | - | - | - | - |
D. Own shares (stocks) | 0,00 | 0,00 | - | - | - | - |
Total liabilities | 167 581,29 | 163 231,76 | 126 747,70 | 138 499,91 | 115 712,05 | 104 656,04 |
A. Equity | 113 203,61 | 129 924,11 | 112 702,03 | 115 782,48 | 105 554,73 | 94 930,55 |
B. Liabilities and provisions for liabilities | 54 377,68 | 33 307,65 | 14 045,67 | 22 717,43 | 10 157,32 | 9 725,49 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.